Ecdysteroids, Phenolics, and Alkaloids From a Mangrove-Derived Fungus Aspergillus sp. BCXT-22.1 With Cytotoxic and NO Inhibitory Activities
- PMID: 40712092
- DOI: 10.1002/cbdv.202501213
Ecdysteroids, Phenolics, and Alkaloids From a Mangrove-Derived Fungus Aspergillus sp. BCXT-22.1 With Cytotoxic and NO Inhibitory Activities
Abstract
An EtOAc extract from the fermentation culture of a mangrove-derived fungus, Aspergillus sp. BCXT-22.1, was investigated, leading to the isolation and structural elucidation of 10 secondary metabolites, including two new compounds, polyporusterone H (1) and stellatinol A (4), along with eight known compounds, panuosterone (2), makisterone A (3), stellatin (5), embeurekol C (6), oxepinamide D (7), oxepinamide F (8), oxepinamide J (9), and protubonine B (10). All of the isolated compounds, except for 8, showed cytotoxicity toward both MCF-7 and SK-Mel-2 cell lines, with IC50 values ranging from 65.38 ± 1.17 to 94.20 ± 3.41 µM. Compound 1 additionally displayed cytotoxicity toward HepG2 cells (IC50 = 87.65 ± 3.49 µM), while exhibiting no cytotoxicity toward the normal human embryonic kidney cell line-293A (HEK-293A) cell line. Besides, compounds 4 and 8 weakly inhibited nitric oxide (NO) overproduction in lipopolysaccharide (LPS)-stimulated BV2 cells, with inhibition rates of 36.6% ± 1.3% and 31.7% ± 2.9% at 40 µM, respectively. Molecular docking simulations suggested that 4 and 8 may exert their NO inhibitory effects by interacting with the active site of the inducible nitric oxide synthase (iNOS) protein, thereby modulating its activity.
Keywords: Aspergillus; Sonneratia caseolaris; alkaloids; cytotoxic; ecdysteroids; mangrove‐derived fungus; nitric oxide; phenolics.
© 2025 Wiley‐VHCA AG, Zurich, Switzerland.
References
-
- S. L. Jia, Z. Chi, G. L. Liu, Z. Hu, and Z. M. Chi, “Fungi in Mangrove Ecosystems and Their Potential Applications,” Critical Reviews in Biotechnology 40 (2020): 852–864.
-
- H. Thatoi, B. C. Behera, and R. R. Mishra, “Ecological Role and Biotechnological Potential of Mangrove Fungi: A Review,” Mycology 4 (2013): 54–71.
-
- Y. Yu, Z. Wang, D. Xiong, L. Zhou, F. Kong, and Q. Wang, “New Secondary Metabolites of Mangrove‐Associated Strains,” Marine Drugs 22 (2024): 372.
-
- S. Chen, R. Cai, Z. Liu, H. Cui, and Z. She, “Secondary Metabolites From Mangrove‐Associated Fungi: Source, Chemistry and Bioactivities,” Natural Product Reports 39 (2022): 560–595.
-
- M. Tian, H. Dai, X. Li, and B. Wang, “Chemical Constituents of Marine Medicinal Mangrove Plant Sonneratia caseolaris,” Chinese Journal of Oceanology and Limnology 27 (2009): 288–296.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
